Education
About Us
Working with TipRanks
Follow Us
Oncopeptides AB (SE:ONCO)
:ONCO
See the Price Targets and Ratings of:
ONCO Financial Forecast
Best Analysts Covering Oncopeptides AB
1 Month
No data currently available
3 Months
No data currently available
1 Year
Success Rate
0/1 ratings generated profit
Average Return
-139.50%
downgraded a sell rating 2 months ago
Copying Dex Genotek's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of -139.50% per trade.
2 Years
No data currently available
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ONCO Analyst Recommendation Trends
Rating
Sep 21
Oct 21
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
1
1
11
Sell
1
1
1
2
1
Strong Sell
4
3
1
0
0
total
5
4
3
3
12
Each month's total comprises the sum of three months' worth of ratings.
ONCO Stock Forecast FAQ
What is SE:ONCO’s average 12-month price target, according to analysts?
Based on analyst ratings, Oncopeptides AB’s 12-month average price target is 1.50.
What is SE:ONCO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:ONCO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Oncopeptides AB a Buy, Sell or Hold?
Oncopeptides AB has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Oncopeptides AB’s share price target?
The average share price target for Oncopeptides AB is 1.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr1.50 ,and the lowest forecast is kr1.50. The average share price target represents -67.67% Decrease from the current price of kr4.64.
The highest analyst share price target is kr1.50 ,and the lowest forecast is kr1.50. The average share price target represents -67.67% Decrease from the current price of kr4.64.
What do analysts say about Oncopeptides AB?
Oncopeptides AB’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Oncopeptides AB?
To buy shares of SE:ONCO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.